Viewing Study NCT05537766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2026-01-25 @ 1:18 PM
Study NCT ID: NCT05537766
Status: TERMINATED
Last Update Posted: 2025-03-03
First Post: 2022-09-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Sponsor: Kite, A Gilead Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Waldenstrom Macroglobulinemia View
None Relapsed/Refractory Richter Transformation View
None Relapsed/Refractory Burkitt Lymphoma View
None Relapsed/Refractory Hairy Cell Leukemia View
Keywords: